Form 8-K - Current report:
SEC Accession No. 0000950170-24-114839
Filing Date
2024-10-16
Accepted
2024-10-16 07:01:05
Documents
13
Period of Report
2024-10-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20241016.htm   iXBRL 8-K 43188
2 EX-99.1 acet-ex99_1.htm EX-99.1 25298
3 GRAPHIC img94724212_0.jpg GRAPHIC 3104
  Complete submission text file 0000950170-24-114839.txt   193524

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20241016.xsd EX-101.SCH 25038
16 EXTRACTED XBRL INSTANCE DOCUMENT acet-20241016_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 241373265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)